Biography
Chad Pollard, PhD, is an adjunct faculty member in BYU’s Department of Cell Biology and Physiology and CEO and Co-Founder of Renew Biotechnologies. His academic and professional work focuses on genomics, epigenetics, biotechnology, and the translation of scientific discoveries into research and clinical applications. His own path from BYU research to biotechnology entrepreneurship gives him firsthand experience navigating the life science innovation process, including technology development, intellectual property, company formation, funding, regulatory strategy, and commercialization. In the Bio-Innovations curriculum, Chad focuses on helping students understand how discoveries made in academic settings can be developed into viable technologies and ventures that address meaningful problems and positively impact lives.
Research Interests
Research interests focus on genomics, epigenetics, and the development of novel molecular approaches for understanding human disease and advancing precision medicine. His work emphasizes cell-free DNA, DNA methylation, and multi-omics methods to discover biomarkers and translate biological signals into clinically meaningful research tools and diagnostics.Teaching Interests
Teaching interests focus on life science innovation, biotechnology entrepreneurship, and translating academic research into technologies with real-world impact. He is particularly interested in helping students navigate the path from scientific discovery to product development, intellectual property, funding, regulatory strategy, and commercialization while developing the skills needed to build successful life science ventures.Education
- Doctor of Philosophy, Cell Biology and Physiology , Brigham Young University (2025)
- Bachelor of Science, Genetics, Genomics, and Biotechnology , Brigham Young University (2022)
